ribociclib
novartis
['ribo', 'ribociclib', 'bcsm']
"this is the first randomized trial to show the benefit of ribociclib and switching endocrine therapy after progression on a cdk4/6 inhibitor, -kevin kalinsky, md, ms, . #asco22 #bcsm 
Oncology news and insights from leading researchers and cancer centers.